This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Mass General Brigham researchers used real-world data to conduct a head-to-head study to investigate cardioprotective effects, finding both medications reduced risk ...

Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shockSeries C round was supported by both existing and new investorsHennigsdorf/Berlin, November 13, 2025 ...

New data on causes of death reveals more than 17,500 people died of dementia in 2024 nationwide, according to the Australian ...

Mortality/major ischemic events at 90 days were no lower than with a restrictive strategy—but cardiac complications differed.

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...

Researchers have long-suspected what microplastics do to our bodies. New data focuses on the gut microbiome and more as ...

After 24 months, 34% of veterans who have heart and blood vessel disease and high cholesterol in a quality improvement ...

A federal judge late Friday issued a preliminary injunction blocking the Trump administration from imposing a $1.2-billion ...

Stable year-over-year and sequentially, following resolution of logistical delays that delayed new product launches until ...

Background: Cardiovascular disease (CVD) prevalence is rising among younger women in the US. Hypertensive disorders of pregnancy (HDP) are early indicators of cardiovascular risk, yet it remains ...